The purpose of pre-consultation meetings with the MFDS is to provide pharmaceutical companies an opportunity to discuss their drug development plans and regulatory requirements. These meetings help clarify submission processes, address potential concerns, and ensure that applicants understand expectations, facilitating smoother applications and enhancing compliance with regulations throughout the drug approval process.